The Use of Point-of-Care Hemoglobin Measurements in an Elderly Population with Hematological Disorders and Anemia
Hematology Reports · 30.06.2026 · 18 (4) · 45
DOI: 10.3390/hematolrep18040045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology Reports, online erschienen am 30.06.2026. Verfasst von Ittai Appel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with severe chronic anemia often require frequent blood transfusions. Many are elderly with comorbidities and limited mobility, making regular hospital visits burdensome. In some cases, patients may receive transfusions despite hemoglobin levels being above the clinical threshold due to logistical challenges, leading to unnecessary exposure to risks, inefficient use of blood units, and resource strain. This study aims to evaluate the use of point-of-care (POC) hemoglobin measurements under controlled outpatient clinic conditions, as an initial step toward potential future home-based monitoring by the patients or their caregivers, with the goal of optimizing transfusion timing, aiming to reduce unnecessary hospital visits while maintaining patient safety.
Methods
A total of 127 patients from a hemato-oncology outpatient clinic at Carmel Medical Center were evaluated using a nurse-operated POC device to sample capillary blood, with 236 paired measurements concurrently analyzed via venous blood in the laboratory. Demographic and clinical data were assessed to evaluate factors associated with agreement between POC and laboratory measurements. Statistical analysis included Bland–Altman plots and Pearson correlation coefficients.
Results
The POC device showed a moderate correlation with laboratory results (r = 0.73, p < 0.001), with a mean difference of 1.20 g/dL (SD = 1.94 g/dL) but wide limits of agreement (−3.20 to 5.50 g/dL). No significant differences were observed across demographic or clinical subgroups. Notably, all 156 paired measurements with POC-measured hemoglobin >7 g/dL were confirmed by laboratory testing.
Conclusions
Although POC hemoglobin devices are not suitable as standalone tools for routine monitoring of chronic anemia, the high negative predictive value observed at the 7 g/dL threshold suggests that they may be useful for ruling out severe anemia. If validated in larger multicenter and home-use studies, POC Hb devices might contribute to reducing unnecessary hospital visits and transfusions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3109601, Israel.
- Institute of Hematology, Lady Davis Carmel Medical Center, Haifa 3436212, Israel.
- Department of Epidemiology, Lady Davis Carmel Medical Center, Haifa 3436212, Israel.
ORCID-Profile: Amir Warwar
Zitieren
APA
Appel, I., Dizengoff, L., Stein, N., Draliuk, R., Kravits, A., Perek, S., Warwar, A., Zoubi, I., Naamneh, M., Kibari, A., Ballan-Haj, M., Valkovsky, O., Mishchenko, E., & Preis, M. (2026). The Use of Point-of-Care Hemoglobin Measurements in an Elderly Population with Hematological Disorders and Anemia. Hematology Reports, 18(4), 45. https://doi.org/10.3390/hematolrep18040045
Vancouver
Appel I, Dizengoff L, Stein N, Draliuk R, Kravits A, Perek S, et al. The Use of Point-of-Care Hemoglobin Measurements in an Elderly Population with Hematological Disorders and Anemia. Hematology Reports. 2026;18(4):45. doi:10.3390/hematolrep18040045
BibTeX
@article{Appel2026,
author = {Appel, Ittai and Dizengoff, Liat and Stein, Nili and Draliuk, Regina and Kravits, Alla and Perek, Shoshan and Warwar, Amir and Zoubi, Ibrahim and Naamneh, Marwa and Kibari, Adi and Ballan-Haj, Mouna and Valkovsky, Olga and Mishchenko, Elena and Preis, Meir},
title = {The Use of Point-of-Care Hemoglobin Measurements in an Elderly Population with Hematological Disorders and Anemia},
journal = {Hematology Reports},
year = {2026},
volume = {18},
number = {4},
pages = {45},
doi = {10.3390/hematolrep18040045}
}
EUVIMED